The patent covers the use of ISC-hpNSC®, ISCO’s proprietary neural stem cells derived from human parthenogenetic stem cells, for the treatment of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease and amyotrophic lateral sclerosis. This patent also covers the use of neural cells derived from other human pluripotent stem cell sources, such as human embryonic stem cells (hESC) and induced pluripotent stem (iPS) cells.
International Stem Cell Corporation Grant... - Cure Parkinson's
International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
5 Replies
•
I found the title, but I can't find the patent itself:
US10039794 - Use of neural cells derived from human pluripotent stem cells for the treatment of human neurodegenerative diseases.
Anyone else have more luck?
For anyone who might like some background information:
globenewswire.com/news-rele...
(this news release contains a link to a research paper)
Not what you're looking for?
You may also like...
More Stem Cell Success!
A new therapeutic approach in which patient-derived dopamine-producing neurons are transplanted...
Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease
Credit to @[1619734] and @[1511265] !
Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety...
International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial
Interim results of this study will be presented at the upcoming 2019 American Academy of Neurology...
Approved Stem Cell Therapy Developed in Korea Begins Treatment for Parkinson's Disease Patients Worldwide in Japan
https://www.bignewsnetwork.com/news/274040185/stem-cell-therapy-developed-in-korea-begins-treatment-